Form 4 Tracker
Bicara Therapeutics Inc.
BCAX

43 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 15, 2025Oct 15 8:20 PMCohlhepp Ryan
Proposed Sale
12,500$18.13$226.6K

View →

Oct 15, 2025Oct 15 8:18 PMMazumdar Claire
Proposed Sale
13,289$18.84$250.4K

View →

Oct 13, 2025Oct 14 1:05 PMMazumdar Claire
Proposed Sale
11,445$18.92$216.5K

View →

Oct 9, 2025Oct 9 8:31 PMHyep Ivan
Proposed Sale
6,415$17.89$114.8K

View →

Oct 9, 2025Oct 9 8:08 PMRaben David
Proposed Sale
22,000$18.45$405.9K

View →

Oct 8, 2025Oct 8 8:04 PMHyep Ivan
Proposed Sale
5,627$18.17$102.2K

View →

Oct 7, 2025Oct 7 8:20 PMHyep Ivan
Proposed Sale
18,244$18.00$328.4K

View →

Oct 7, 2025Oct 7 8:07 PMCohlhepp Ryan
Proposed Sale
10,900$18.00$196.2K

View →

Oct 6, 2025Oct 6 8:36 PMCohlhepp Ryan
Proposed Sale
39,600$18.06$715.0K

View →

Oct 6, 2025Oct 6 8:07 PMHyep Ivan
Proposed Sale
6,514$17.04$111.0K

View →

Sep 29, 2025Sep 29 8:38 PMLARA MEISNER
Proposed Sale
33,807$11.71$395.9K

View →

Jun 16, 2025Jun 16 8:29 PMLARA S. MEISNER
Proposed Sale
31,658$10.84$343.2K

View →

Mar 14, 2025Mar 14 8:21 PMLARA S. MEISNER
Proposed Sale
79,146$13.35$1.1M

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 12, 2026Aug 14 8:54 PMJennifer LarsonChief Financial Officer
Grant/Award
285,000$24.63285,000(D)

View →

Aug 10, 2026Aug 12 8:19 PMIvan HyepChief Financial Officer
Option Exercise
12,500$3.7926,336(D)

View →

Aug 10, 2026Aug 12 8:19 PMClaire MazumdarDirector, Chief Executive Officer
Option Exercise
10,000$3.79110,546(D)

View →

Aug 10, 2026Aug 12 8:19 PMRyan CohlheppDirector, President and COO
Option Exercise
18,750$3.7951,752(D)

View →

Jul 28, 2026Jul 29 8:18 PMJeremy BenderDirector
Grant/Award
38,950$26.8838,950(D)

View →

Jul 28, 2026Jul 29 8:18 PMChristy J. OligerDirector
Grant/Award
38,950$26.8838,950(D)

View →

Jul 10, 2026Jul 14 8:22 PMClaire MazumdarDirector, Chief Executive Officer
Option Exercise
10,000$3.79120,546(D)

View →

Jul 8, 2026Jul 10 8:10 PMRyan CohlheppDirector, President and COO
Option Exercise
18,750$3.7970,502(D)

View →

Jul 8, 2026Jul 10 8:10 PMIvan HyepChief Financial Officer
Option Exercise
12,500$3.7938,836(D)

View →

Jun 9, 2026Jun 10 8:43 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
19,475$20.5619,475(I)

View →

Jun 9, 2026Jun 10 8:35 PMChristopher BowdenDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:34 PMKate HavilandDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:34 PMKiran Mazumdar-ShawDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:33 PMScott M. RobertsonDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:33 PMMichael PowellDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:32 PMJake SimsonDirector
Grant/Award
19,475$20.5619,475(D)

View →

May 21, 2026May 26 9:48 PMIvan HyepChief Financial Officer
Option Exercise
9,200$3.7970,584(D)

View →

May 18, 2026May 20 8:07 PMClaire MazumdarDirector, Chief Executive Officer
Option Exercise
15,000$3.79146,107(D)

View →

May 15, 2026May 18 8:24 PMRyan CohlheppDirector, President and COO
Option Exercise
8,000$3.79101,334(D)

View →

May 8, 2026May 12 8:04 PMWilliam SchelmanChief Medical Officer
Grant/Award
85,000$22.5885,000(D)

View →

Page 1 of 3

Next →